|
End-of-day quote
Korea S.E.
2026-09-14
|
5-day change | 1st Jan Change | ||
| 16,270.00 KRW | -3.56% |
|
-10.90% | -71.66% |
| 07-23 | Samsung EpiS Unit Signs Cancer Drug Development, Commercialization Deal with IntoCell | MT |
| 12-21 | IntoCell, Inc.(KOSDAQ:A287840) added to S&P Global BMI Index | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.56% | -10.90% | -25.37% | -27.20% | -71.66% | -57.85% | - | - | - | 189M | |
| +0.56% | -5.82% | -6.74% | +8.95% | -0.67% | -2.45% | +9.99% | -29.88% | +195.30% | 45.48B | |
| +0.66% | -2.34% | +1.54% | +33.30% | +157.51% | +340.62% | +524.38% | +593.41% | - | 43.68B | |
| +1.49% | -0.78% | +10.00% | +46.41% | +17.86% | +41.90% | +22.65% | +3.95% | +242.67% | 43.09B | |
| +2.11% | -1.24% | -0.61% | +33.78% | +16.46% | +9.09% | +76.85% | -2.86% | +1,017.24% | 39.4B | |
| +0.34% | -4.94% | -11.49% | +3.35% | +3.72% | +9.34% | +40.23% | -16.99% | +135.16% | 31.91B | |
| +0.53% | -2.08% | +7.59% | +21.49% | - | - | - | - | - | 17.31B | |
| +1.34% | +0.70% | +2.31% | +27.40% | +6.01% | +21.35% | +111.39% | +220.75% | +1,896.68% | 16.4B | |
| +2.07% | -0.77% | +2.94% | +12.61% | +15.64% | +13.07% | +32.89% | -40.67% | +92.84% | 14.24B | |
| -1.85% | -5.33% | -2.90% | +45.65% | +36.91% | +78.63% | +34.13% | -36.67% | +243.02% | 13.28B | |
| -0.22% | +2.47% | +0.87% | +15.56% | -7.29% | -3.47% | -36.28% | -34.21% | +122.66% | 13.06B | |
| +0.21% | -0.22% | +0.14% | +33.83% | +22.89% | +40.99% | -0.30% | -42.48% | +173.80% | 11.31B | |
| +5.42% | -3.73% | +14.59% | +30.09% | +5.35% | -27.98% | - | - | - | 10.65B | |
| -1.63% | +2.10% | -6.52% | +17.17% | -17.23% | +40.95% | +506.14% | +207.09% | +2,448.59% | 10.25B | |
| +5.88% | +3.54% | -14.36% | +90.57% | +50.02% | +26.37% | +56.74% | -50.15% | - | 10.13B | |
| -0.27% | +1.41% | -2.40% | +34.61% | +69.20% | +151.07% | +701.41% | +225.58% | +1,047.36% | 9.59B | |
| -0.29% | -2.35% | +0.18% | +32.97% | +47.32% | +143.95% | +490.27% | +80.66% | - | 9.56B | |
| -1.20% | -6.04% | -10.29% | +24.00% | +12.15% | +776.67% | +1,569.45% | +6.35% | - | 9.34B | |
| +5.07% | +8.07% | +30.87% | +161.14% | +173.75% | +95.63% | +79.32% | +5.10% | +1,346.81% | 9.02B | |
| -5.11% | -11.45% | -7.93% | -29.80% | -34.98% | -18.56% | +19.21% | +41.83% | +74.85% | 9.01B | |
| Average | +0.59% | -2.29% | -0.88% | +30.79% | +26.47% | +88.39% | +249.32% | +66.52% | +695.15% | 18.34B | |
| Weighted average by Cap. | +0.95% | -2.65% | +0.04% | +29.87% | +34.95% | +86.90% | +187.87% | +90.72% | +567.26% |
- Stock Market
- Stocks
- A287840 Stock
- Sector IntoCell, Inc.
Select your edition
All financial news and data tailored to specific country editions
